Read More: Cognito Shares HOPE Study Results at CTAD Cognito Shares HOPE Study Results at CTAD Business Wire 11.16.2026
Read More: Cognito Expands Executive Leadership Team Cognito Expands Executive Leadership Team Business Wire 11.12.2026
Read More: Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer’s Disease Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer’s Disease PR Newswire 10.13.2026
Read More: Cognito Therapeutics Presents Exploratory Biomarker Data at AAIC 2026 Supporting Coordinated Modulation of Lipid Transport and Myelination Pathways Cognito Therapeutics Presents Exploratory Biomarker Data at AAIC 2026 Supporting Coordinated Modulation of Lipid Transport and Myelination Pathways Business Wire 07.13.2026
Read More: Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026 Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026 Business Wire 06.22.2026
Read More: Cognito Partners with Initiative to Change the “D-Word” Cognito Partners with Initiative to Change the “D-Word” Business Wire 04.08.2026